Tomocube Inc
KOSDAQ:475960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tomocube Inc
Additional Paid In Capital
Tomocube Inc
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tomocube Inc
KOSDAQ:475960
|
Additional Paid In Capital
₩97.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ESR Kendall Square REIT Co Ltd
KRX:365550
|
Additional Paid In Capital
₩896.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
202%
|
CAGR 10-Years
N/A
|
|
|
Lotte REIT Co Ltd
KRX:330590
|
Additional Paid In Capital
₩1.2T
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
T
|
Taesung Co Ltd
KOSDAQ:323280
|
Additional Paid In Capital
₩24.2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
C
|
Curiox BioSystems Co Ltd
KOSDAQ:445680
|
Additional Paid In Capital
₩89B
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
SK Eternix Co Ltd
KRX:475150
|
Additional Paid In Capital
₩213.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tomocube Inc
Glance View
Tomocube Inc is a KR-based company operating in industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2024-11-07. TomoCube Inc is a Korea-based company primarily engaged in manufacturing and selling of imaging devices used in life science research and diagnostics. The Company’s holotomography (HT) technology uses light diffraction to obtain three-dimensional (3D) images of cells and tissues without dyeing or labeling. This technology can be used to reconstruct the refractive index (RI) distribution of cells in real time as a 3D image, which can be applied to cell therapy and organoid research, life science research and diagnostics.
See Also
What is Tomocube Inc's Additional Paid In Capital?
Additional Paid In Capital
97.9B
KRW
Based on the financial report for Dec 31, 2024, Tomocube Inc's Additional Paid In Capital amounts to 97.9B KRW.
What is Tomocube Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 1Y
47%
Over the last year, the Additional Paid In Capital growth was 47%.
